Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_assertion type Assertion NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_head.
- NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_assertion description "[We recommend to include in the FXTAS testing guidelines both CCS hyperintensity and peripheral neuropathy and to consider them as new major radiologic and minor clinical criterion, respectively, for the diagnosis of FXTAS.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_provenance.
- NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_assertion evidence source_evidence_literature NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_provenance.
- NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_assertion SIO_000772 23077007 NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_provenance.
- NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_assertion wasDerivedFrom befree-20140225 NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_provenance.
- NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_assertion wasGeneratedBy ECO_0000203 NP712881.RAmOk3bZksWDpFfSBG8fwXfWSuxVUvUzpg-4uqzGdon7w130_provenance.